Cargando…
Nanoparticles carrying paclitaxel and anti-miR-221 for breast cancer therapy triggered by ultrasound
Nanomaterials have been well demonstrated to have the potential to be used for tumor cell-targeted drug delivery. Targeted inhibition of miR-221 was proved to promote the sensitivity of triple genitive breast cancer (TNBC) cells to chemo-drugs. In order to improve the chemotherapeutic effect in TNBC...
Autores principales: | Zhang, Libo, Ren, Zhen, Lü, Jinhui, Mo, Xinhai, Lin, Jie, Li, Ya, Ma, Wenjing, Liu, Pengfei, Shen, Yajing, Zhao, Qian, Qian, Lu, Cheng, Xiaoxin, Yu, Zuoren, Zhang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427607/ https://www.ncbi.nlm.nih.gov/pubmed/37582832 http://dx.doi.org/10.1038/s41420-023-01594-9 |
Ejemplares similares
-
Reck-Notch1 Signaling Mediates miR-221/222 Regulation of Lung Cancer Stem Cells in NSCLC
por: Guo, Yuefan, et al.
Publicado: (2021) -
Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells
por: Li, Shujun, et al.
Publicado: (2020) -
Piwi-Interacting RNAs: A New Class of Regulator in Human Breast Cancer
por: Qian, Lu, et al.
Publicado: (2021) -
Role of miR-221/222 in Tumor Development and the Underlying Mechanism
por: Song, Qian, et al.
Publicado: (2019) -
miR-221/222 Promotes S-Phase Entry and Cellular Migration in Control of Basal-Like Breast Cancer
por: Li, Yuan, et al.
Publicado: (2014)